A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-2)
Research Grant
Awarded By
4D Molecular Therapeutics
Start Date
July 29, 2025
End Date
December 14, 2028
Awarded By
4D Molecular Therapeutics
Start Date
July 29, 2025
End Date
December 14, 2028